Balchem Corporation (BCPC)
Market Cap | 4.14B |
Revenue (ttm) | 922.96M |
Net Income (ttm) | 108.91M |
Shares Out | 32.14M |
EPS (ttm) | 3.35 |
PE Ratio | 38.47 |
Forward PE | 31.55 |
Dividend | $0.71 (0.55%) |
Ex-Dividend Date | Dec 23, 2022 |
Volume | 65,545 |
Open | 128.72 |
Previous Close | 129.37 |
Day's Range | 127.46 - 130.05 |
52-Week Range | 110.15 - 148.05 |
Beta | 0.69 |
Analysts | Buy |
Price Target | 158.78 (+23.2%) |
Earnings Date | Feb 17, 2023 |
About BCPC
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and ... [Read more]
Financial Performance
In 2021, Balchem's revenue was $799.02 million, an increase of 13.56% compared to the previous year's $703.64 million. Earnings were $96.10 million, an increase of 13.57%.
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for BCPC stock is "Buy." The 12-month stock price forecast is $158.78, which is an increase of 23.20% from the latest price.
News

Balchem Corporation Named on Newsweek's 2023 List of America's Most Responsible Companies
MONTVALE, N.J., Jan. 06, 2023 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) announced that the Company has been named one of America's Most Responsible Companies by Newsweek and Statista Inc....

Balchem Corporation to Present at the CJS Securities 23rd Annual “New Ideas for the New Year” Investor Conference January 11, 2023
MONTVALE, N.J., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) Chief Financial Officer Martin Bengtsson will present at the CJS Securities 23rd Annual “New Ideas for the New Year...

Balchem Corporation Announces Dividend
MONTVALE, N.J., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that on December 5, 2022, its Board of Directors declared a dividend on its shares of common stock ...

Blachem (BCPC) Q3 Earnings Miss Estimates
Blachem (BCPC) delivered earnings and revenue surprises of -14.29% and 1.36%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Balchem Corporation Reports Third Quarter Sales of $244.3 Million, Net Earnings of $25.2 Million, GAAP EPS of $0.78, and Adjusted EPS of $1.00
MONTVALE, N.J., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today third quarter net earnings of $25.2 million for 2022, compared to net earnings of $25.0 million for ...

Balchem Corporation Announces Quarterly Conference Call for Third Quarter Financial Results on November 4, 2022
MONTVALE, N.J., Oct. 21, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, November 4th at 11:00 AM Eastern Time (ET) to review...

Blachem (BCPC) Moves to Strong Buy: Rationale Behind the Upgrade
Blachem (BCPC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Bears are Losing Control Over Blachem (BCPC), Here's Why It's a 'Buy' Now
Blachem (BCPC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a tre...

Balchem Corporation acquires Bergstrom Nutrition
NEW HAMPTON, N.Y., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredients company focused on Nutrition and Health, today announced the acquisition of Cardi...

Will Blachem (BCPC) Gain on Rising Earnings Estimates?
Blachem (BCPC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Best Momentum Stocks to Buy for August 24th
BCPC, KEYS and AHT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 24, 2022.

Blachem (BCPC) Q2 Earnings and Revenues Top Estimates
Blachem (BCPC) delivered earnings and revenue surprises of 9.52% and 6.62%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Balchem Corporation Reports Second Quarter Sales of $236.7 Million, Net Earnings of $29.8 Million, GAAP EPS of $0.92, and Adjusted EPS of $1.07
NEW HAMPTON, N.Y., July 29, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today second quarter net earnings of $29.8 million for 2022, compared to net earnings of $22.7 million ...

Blachem (BCPC) Upgraded to Buy: Here's What You Should Know
Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Balchem Corporation Announces Quarterly Conference Call for Second Quarter Financial Results on July 29, 2022
NEW HAMPTON, N.Y., July 15, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, July 29th at 11:00 AM Eastern Time (ET) to review...

Balchem Corporation Completes Acquisition of Kappa Bioscience AS
NEW HAMPTON, N.Y., June 21, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredients company focused on Nutrition and Health, today announced that it completed its ac...

What Makes Blachem (BCPC) a New Strong Buy Stock
Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Balchem Corporation Signs Definitive Agreement to Acquire Kappa Bioscience AS
NEW HAMPTON, N.Y., June 14, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredients company focused on Nutrition and Health, has signed a definitive agreement to acq...

3 Reasons Growth Investors Will Love Blachem (BCPC)
Blachem (BCPC) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Blachem (BCPC) Q1 Earnings and Revenues Surpass Estimates
Blachem (BCPC) delivered earnings and revenue surprises of 21.92% and 8.47%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Balchem Corporation Reports First Quarter Sales of $228.9 Million, Net Earnings of $28.9 Million, GAAP EPS of $0.89, and Adjusted EPS of $1.03
NEW HAMPTON, N.Y., April 29, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today first quarter net earnings of $28.9 million for 2022, compared to net earnings of $23.4 million ...

Balchem Releases 2021 Sustainability Report
NEW HAMPTON, N.Y., April 22, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today released its 2021 Sustainability Report, which captures the Company's commitment to managing our Environm...

Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on April 29, 2022
NEW HAMPTON, N.Y., April 15, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, April 29th at 11:00 AM Eastern Time (ET) to revi...

Balchem Corporation Reports Record Fourth Quarter Sales of $213.1 Million and Net Earnings of $24.9 Million, GAAP EPS of $0.76 and Adjusted EPS of $0.85
NEW HAMPTON, N.Y., Feb. 18, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today fourth quarter net earnings of $24.9 million for 2021, compared to net earnings of $22.2 million ...

Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter Financial Results on February 18, 2022
NEW HAMPTON, N.Y., Feb. 04, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, February 18th at 11:00 AM Eastern Time (ET) to re...